CCL20 and colorectal carcinoma: It has been shown that 5-FU therapy increased the expression of chemokine (CCL20) in colorectal carcinoma cells (CRC) in vivo by triggering FOXO1/CEBPB/NF-κB signaling, which aided in the migration of Tregs into TME.